Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Takeda: A Prospective, Multicenter Registry for Patients with Short Bowel Syndrome
Chawla, A. (PI), Gathungu, G. (CoPI), Morganstern, J. A. (CoPI) & Tobin, M. (CoPI)
Shire-NPS Pharmaceuticals Incorporated
04/29/16 → 07/29/27
Project: Research
-
A Long-Term, Non-Interventional Registry to Assess Safety and Effectiveness of Humira (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD) - CAPE
Morganstern, J. A. (PI), Chawla, A. (CoPI), Gathungu, G. (CoPI), Small-Harary, L. (CoPI) & Tobin, M. (CoPI)
10/2/15 → 03/4/27
Project: Research
-
Takeda: A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease
Chawla, A. (PI), Breglio, K. (CoPI), Gathungu, G. (CoPI), Lee, A. (CoPI), Morganstern, J. A. (CoPI), Small-Harary, L. (CoPI) & Tobin, M. (CoPI)
04/3/24 → 04/2/25
Project: Research
-
Evaluation of a 7-Day Therapeutic Trial Dose of Commercial Sucraid (sacrosidase) Oral Solution for Alleviating Congenital Sucrase-Isomaltase Deficiency (CSID) Symptoms in Pediatric Subjects with Low, Moderate, and Normal Sucrase Levels
Small-Harary, L. (PI), Breglio, K. (CoPI), Chawla, A. (CoPI), Gathungu, G. (CoPI), Lee, A. (CoPI), Morganstern, J. A. (CoPI) & Tobin, M. (CoPI)
05/5/23 → 03/29/26
Project: Research
-
Takeda: A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatrics Subjects with Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response
Chawla, A. (PI), Breglio, K. (CoPI), Gathungu, G. (CoPI), Lee, A. (CoPI), Morganstern, J. A. (CoPI), Small-Harary, L. (CoPI) & Tobin, M. (CoPI)
08/24/21 → 11/16/25
Project: Research
-
Gastroesophageal reflux and PPI exposure alter gut microbiota in very young infants
Francis, D., Chawla, A., LaComb, J. F., Markarian, K., Robertson, C. E., Frank, D. N. & Gathungu, G. N., Feb 8 2023, In: Frontiers in Pediatrics. 11, 1254329.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Gut Microbiota Profiles of Children with Obesity or Metabolic Syndrome: Body Mass Index Is a Lead Actor
Gathungu, G. N., Frank, D. N., Chawla, A., Robertson, C. E., LaComb, J. F., Markarian, K., Burghard, B. M. & Woroniecki, R., Sep 2023, In: Obesities. 3, 3, p. 253-264 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Younger Patients Do Not Develop More Advanced Polyps on Surveillance Colonoscopy Than Their Index Colonoscopy When Compared with Older Patients
Mizrahi, J., Shah, K., Myer, A., Sheyman, M., Meier, K., Redhead, K. R., Williams, J., Aroniadis, O., Desai, D. & Gathungu, G., Oct 1 2022, In: Journal of Clinical Gastroenterology. 56, 9, p. 772-780 9 p.Research output: Contribution to journal › Article › peer-review
-
Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome
Liid, E., Zhang, Y., Tian, X., Wang, X., Gathungu, G., Wolber, A., Shiekh, S. S., Sartor, R. B., Davidson, N. O., Ciorba, M. A., Zhu, W., Nelson, L. M., Robertson, C. E. & Frank, D. N., Feb 2019, In: PLoS ONE. 14, 2, e0213108.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal crohn's disease
Gathungu, G., Zhang, Y., Tian, X., Bonkowski, E., Rowehl, L., Krumsiek, J., Nix, B., Chalk, C., Trapnell, B., Zhu, W., Newberry, R., Denson, L. & Li, E., Feb 7 2018, In: World Journal of Gastroenterology. 24, 5, p. 623-630 8 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations